LONDON (AP) - Britain will be the first country to run final stage trials of an experimental coronavirus vaccine being developed by the pharmaceutical company Janssen, a subsidiary of Johnson & Johnson.
Scientists will begin recruiting some 6,000 people across the U.K. on Monday for the 12-month trial.
...from www.washingtontimes.com stories: Health https://ift.tt/38MsRTm